Flumioxazin; Pesticide Tolerances, 91846-91852 [2016-30467]
Download as PDF
91846
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
action must be filed in the United States
Court of Appeals for the appropriate
circuit by February 17, 2017. Filing a
petition for reconsideration by the
Administrator of this final rule does not
affect the finality of this action for the
purposes of judicial review nor does it
extend the time within which a petition
for judicial review may be filed, and
shall not postpone the effectiveness of
such rule or action. This action may not
be challenged later in proceedings to
enforce its requirements. (See section
307(b)(2).)
List of Subjects in 40 CFR Part 81
Environmental protection,
Administrative practice and procedure,
Air pollution control, Designations and
classifications, Intergovernmental
relations, Nitrogen oxides, Ozone,
Reporting and recordkeeping
requirements, Volatile organic
compounds.
Dated: December 7, 2016.
Robert A. Kaplan,
Acting Regional Administrator, Region 5.
Part 81, title 40, chapter I of the Code
of Federal Regulations is amended as
follows:
PART 81—DESIGNATION OF AREAS
FOR AIR QUALITY PLANNING
PURPOSES
1. The authority citation for part 81
continues to read as follows:
■
Authority: 42 U.S.C. 7401 et seq.
2. Section 81.350 is amended by
revising the entry for Sheboygan
County, WI in the table entitled
‘‘Wisconsin—2008 8-Hour Ozone
NAAQS (Primary and secondary)’’ to
read as follows:
■
§ 81.350
*
*
Wisconsin.
*
*
*
WISCONSIN—2008 8-HOUR OZONE NAAQS
[Primary and secondary]
Designation
Classification
Designated area
Date 1
*
Sheboygan County,
boygan County.
*
WI: 2
*
She-
Type
*
........................
*
Nonattainment ................................
*
*
*
*
*
Date 1
Type
1/18/2017
*
Moderate.
*
*
*
1 This
date is July 20, 2012, unless otherwise noted.
2 Excludes Indian country located in each area, unless otherwise noted.
*
*
*
*
*
[FR Doc. 2016–30330 Filed 12–16–16; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2015–0658; FRL–9955–45]
Flumioxazin; Pesticide Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes
tolerances for residues of flumioxazin in
or on multiple commodities which are
identified and discussed later in this
document. The Inter-Regional Research
Project Number 4 (IR–4) requested these
tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective
December 19, 2016. Objections and
requests for hearings must be received
on or before February 17, 2017, and
must be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action,
identified by docket identification (ID)
srobinson on DSK5SPTVN1PROD with RULES
SUMMARY:
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
number EPA–HQ–OPP–2015–0658, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW., Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington,
DC 20460–0001; Main telephone
number: (703) 305–7090; email address:
RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
PO 00000
Frm 00204
Fmt 4700
Sfmt 4700
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
site at https://www.ecfr.gov/cgi-bin/textidx?&c=ecfr&tpl=/ecfrbrowse/Title40/
40tab_02.tpl.
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
E:\FR\FM\19DER1.SGM
19DER1
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
srobinson on DSK5SPTVN1PROD with RULES
identify docket ID number EPA–HQ–
OPP–2015–0658 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before February 17, 2017. Addresses for
mail and hand delivery of objections
and hearing requests are provided in 40
CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2015–0658, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW., Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
dockets generally, is available at https://
www.epa.gov/dockets.
II. Summary of Petitioned-For
Tolerance
In the Federal Register of November
23, 2015 (80 FR 72941) (FRL–9936–73),
EPA issued a document pursuant to
FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP#5E8399) by
Interregional Research No. 4 (IR–4),
Rutgers, The State University of New
Jersey, 500 College Road East, Suite
201–W, Princeton, NJ 08540. The
Agency inadvertently republished this
notice on March 16, 2016 (81 FR 14030)
(FRL–9942–86). The petition requested
that 40 CFR 180.568 be amended by
establishing tolerances for residues of
the herbicide flumioxazin, 2-[7-fluoro3,4-dihydro-3-oxo-4-(2-propynyl)-2H1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro1H-isoindole-1,3(2H)-dione, in or on
berry, low growing, subgroup 13–07G at
0.07 parts per million (ppm); caneberry,
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
subgroup 13–07A at 0.4 ppm; citrus,
group 10–10 at 0.02 ppm; citrus oil at
0.1 ppm; clover, forage at 0.02 ppm;
clover, hay at 0.15 ppm; fruit, pome,
group 11–10 at 0.02 ppm; fruit, small
vine climbing, except for fuzzy
kiwifruit, subgroup 13–07F at 0.02 ppm;
fruit, stone, group 12–12 at 0.02 ppm;
head and stem brassica, subgroup 5A at
0.02 ppm; nut, tree, group 14–12 at 0.02
ppm; onion, bulb subgroup 3–07A at
0.02 ppm; and vegetable, fruiting, group
8–10 at 0.02 ppm.
The petitioner also requested the
removal of the following established
tolerances based on the establishment of
tolerances for the commodities
established in this action: Cabbage at
0.02 ppm; cabbage, Chinese, napa at
0.02 ppm; fruit, pome group 11 at 0.02
ppm; fruit, stone, group 12 at 0.02 ppm;
garlic at 0.02 ppm; grape at 0.02 ppm;
nut, tree group 14 at 0.02 ppm; okra at
0.02 ppm; onion, bulb at 0.02 ppm;
pistachio at 0.02 ppm; shallot bulb at
0.02 ppm; strawberry at 0.07 ppm; and
vegetable, fruiting group 8 at 0.02 ppm.
That document referenced a summary of
the petition prepared by Valent USA
Corporation, the registrant, which is
available in the docket, https://
www.regulations.gov. Comments were
received on these notices of filings.
EPA’s response to these comments is
discussed in Unit IV.C.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue . . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
PO 00000
Frm 00205
Fmt 4700
Sfmt 4700
91847
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for flumioxazin
including exposure resulting from the
tolerances established by this action.
EPA’s assessment of exposures and risks
associated with flumioxazin follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
Toxicity associated with flumioxazin
includes anemia and effects on the
cardiovascular system and liver.
Specifically, alterations in hemoglobin
parameters were observed in rats, as
well as increased renal toxicity in male
rats, and increased absolute and relative
liver weights and increased alkaline
phosphate values were seen in dogs. No
evidence of neurotoxicity was seen in
male or female rats in the acute or
subchronic neurotoxicity studies. The
oral and dermal developmental rat
studies showed evidence of increased
quantitative susceptibility of fetuses, as
cardiovascular anomalies (ventral septal
defects) were found. These
developmental effects in the offspring
were more severe and seen at doses
lower than those that caused parental
and systemic toxicity. The regulatory
endpoints for flumioxazin are protective
of this increased susceptibility,
however, so there is low concern and no
residual uncertainties for these effects.
Flumioxazin was negative for
mutagenicity in most of the available
studies, however, there were aberrations
in a chromosomal aberration assay. The
lack of carcinogenicity in mice and rats
permits flumioxazin to be classified as
‘‘not likely to be carcinogenic to
humans.’’
Specific information on the studies
received and the nature of the adverse
effects caused by flumioxazin as well as
the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found at https://
www.regulations.gov in document
Flumioxazin: Human Health Risk
Assessment for the New Uses on Clover
Grown for Seed; Citrus Group 10–10;
Caneberry Subgroup 13–07A; Head and
Stem Brassica Subgroup 5A; and Crop
Group Expansion for Fruiting Vegetable
Group 8–10; Low Growing Berry
Subgroup 13–07G; Nut Tree Group 14–
12; Onion Bulb Subgroup 3–07A; Pome
E:\FR\FM\19DER1.SGM
19DER1
91848
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
Fruit Group 11–10; Small Fruit, Vine
Climbing, Except Fuzzy Kiwifruit
Subgroup 13–07F; and Stone Fruit
Group 12–12 at pages 15–22 and 42–55
in docket ID number EPA–HQ–OPP–
2015–0658.
srobinson on DSK5SPTVN1PROD with RULES
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which no adverse effects are
observed (the NOAEL) and the lowest
dose at which adverse effects of concern
are identified (the LOAEL). Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
reference dose (RfD)—and a safe margin
of exposure (MOE). For non-threshold
risks, the Agency assumes that any
amount of exposure will lead to some
degree of risk. Thus, the Agency
estimates risk in terms of the probability
of an occurrence of the adverse effect
expected in a lifetime. For more
information on the general principles
EPA uses in risk characterization and a
complete description of the risk
assessment process, see https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/assessinghuman-health-risk-pesticides.
A summary of the toxicological
endpoints for flumioxazin used for
human risk assessment is discussed in
Unit III, B of the final rule published in
the Federal Register of September 21,
2012 (77 FR 58493) (FRL–9358–3).
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to flumioxazin, EPA
considered exposure under the
petitioned-for tolerances as well as all
existing flumioxazin tolerances in 40
CFR 180.568. EPA assessed dietary
exposures from flumioxazin in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure.
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
Such effects were identified for
flumioxazin for females 13–49. In
estimating acute dietary exposure, EPA
used food consumption information
from the Dietary Exposure Evaluation
Model software with the Food
Commodity Intake Database (DEEM–
FCID) Version 3.16. This software uses
2003–2008 food consumption data from
the U.S. Department of Agriculture’s
(USDA’s) National Health and Nutrition
Examination Survey, What We Eat in
America, (NHANES/WWEIA). As to
residue levels in food, EPA incorporated
tolerance-level residues, 100 percent
crop treated (PCT) for all commodities
and DEEM–FCID version 3.16.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the DEEM–FCID Version 3.16.
This software uses 2003–2008 food
consumption data from USDA’s
NHANES/WWEIA. As to residue levels
in food, EPA incorporated tolerancelevel residues, 100 PCT for all
commodities.
iii. Cancer. Based on the data
summarized in Unit III.A., EPA has
concluded that flumioxazin does not
pose a cancer risk to humans. Therefore,
a dietary exposure assessment for the
purpose of assessing cancer risk is
unnecessary.
iv. Anticipated residue and percent
crop treated (PCT) information. EPA did
not use anticipated residue and/or PCT
information in the dietary assessment
for flumioxazin. Tolerance level
residues and/or 100% CT were assumed
for all food commodities.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for flumioxazin in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of flumioxazin.
The estimated drinking water
concentrations (EDWCs) are based on
aquatic rates of the residues of concern
for flumioxazin and its major degradates
(482–HA, and APF), expressed as
flumioxazin equivalents. Further
information regarding EPA drinking
water models used in pesticide
exposure assessment can be found at
https://www2.epa.gov/pesticide-scienceand-assessing-pesticide-risks/aboutwater-exposure-models-used-pesticide.
Based on the First Index Reservoir
Screening Tool (FIRST) model, the
EDWCs in surface water for acute
exposures are 400 parts per billion (ppb)
for flumioxazin only and for chronic
exposures are estimated to be 9.4 ppb,
21.6 ppb, and 110.1 ppb for
flumioxazin, 482–HA and APF
degradates, respectively, for a total
PO 00000
Frm 00206
Fmt 4700
Sfmt 4700
concentration of 141 ppb. Based on the
Screening Concentration in Ground
Water (SCI–GROW) model, for both
acute and chronic (non-cancer)
exposures, the EDWCs of 482–HA and
APF are estimated to be 45.27 ppb and
2.66 ppb, respectively, for ground water.
EDWCs of flumioxazin are estimated to
be negligible in ground water for
chronic exposures.
Estimates of drinking water
concentrations were directly entered
into the dietary exposure model as
follows. The peak day zero of 0.400 ppm
for flumioxazin (degradates 482–HA and
APF were not detected) was used to
assess the contribution to drinking
water for the acute dietary risk
assessment, and the day 30 total of
0.141 ppm for flumioxazin, 482–HA and
APF degradates was used to assess the
contribution to drinking water for the
chronic dietary risk assessment.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Flumioxazin is currently registered for
the following uses that could result in
residential exposures: Turf, gardens and
trees, and aquatic weeds. EPA assessed
residential exposure with the
assumption that homeowner handlers
wear shorts, short-sleeved shirts, socks,
and shoes, and that they complete all
tasks associated with the use of a
pesticide product including mixing/
loading, if needed, as well as the
application. Residential handler
exposure scenarios for both dermal and
inhalation are considered to be shortterm only, due to the infrequent use
patterns associated with homeowner
products.
EPA uses the term ‘‘post-application’’
to describe exposure to individuals that
occur as a result of being in an
environment that has been previously
treated with a pesticide. Flumioxazin
can be used in many areas that can be
frequented by the general population
including residential areas, lakes, and
ponds. As a result, individuals can be
exposed by entering these areas if they
have been previously treated. Therefore,
short-term and intermediate-term
dermal post-application exposures and
risks were assessed for adults and
children. In addition, oral postapplication exposures and risks were
assessed for children to be protective of
possible hand-to-mouth, object-tomouth, and soil ingestion activities that
may occur on treated turf areas. Further
information regarding EPA standard
assumptions and generic inputs for
E:\FR\FM\19DER1.SGM
19DER1
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
srobinson on DSK5SPTVN1PROD with RULES
residential exposures may be found at
https://www2.epa.gov/pesticide-scienceand-assessing-pesticide-risks/standardoperating-procedures-residentialpesticide.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
EPA has not found flumioxazin to
share a common mechanism of toxicity
with any other substances, and
flumioxazin does not appear to produce
a toxic metabolite produced by other
substances. For the purposes of this
tolerance action, therefore, EPA has
assumed that flumioxazin does not have
a common mechanism of toxicity with
other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s Web site at https://
www2.epa.gov/pesticide-science-andassessing-pesticide-risks/cumulativeassessment-risk-pesticides.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA Safety Factor (SF). In applying
this provision, EPA either retains the
default value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
There is evidence of increased
quantitative susceptibility of fetuses in
the oral and dermal developmental rat
studies, where cardiovascular
abnormalities occurred in the absence of
maternal toxicity. The rat reproduction
study also showed evidence of
qualitative and quantitative post-natal
susceptibility since reproductive effects
in offspring were more severe and were
seen at lower doses than those that
caused parental/systemic toxicity. Even
with this observed increased
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
susceptibility, the Agency has
concluded there is a low concern and no
residual uncertainties for pre- and/or
postnatal toxicity because the
developmental toxicity NOAELs/
LOAELs are well-characterized after oral
and dermal exposure, and the offspring
toxicity NOAEL and LOAEL are well
characterized in the reproduction study.
Furthermore, the doses and endpoints
have been selected from the
developmental and reproductive
toxicity studies for risk assessment of
the relevant exposed populations (e.g.,
pregnant females and children), with
the exception of the chronic dietary
endpoint, for which a chronic study was
selected. Therefore, regulatory
endpoints for flumioxazin are protective
of the increased susceptibility and there
are no residual concerns for these
effects.
3. Conclusion. EPA has determined
that reliable data show the safety of
infants and children would be
adequately protected if the FQPA SF
were reduced to 1X for oral and dermal
exposures, but retained at 10X for
inhalation exposures due to the lack of
an inhalation study. That decision is
based on the following findings:
i. The toxicity database for
flumioxazin is sufficient for assessing
the toxicity and characterizing the
hazard of flumioxazin. An inhalation
study is needed to characterize more
completely the potential for adverse
effects associated with the inhalation
route of exposure; therefore, in order to
account for any uncertainty attending
the use of the dose and endpoint from
an oral rat developmental toxicity study
with an estimated 100% default
absorption factor, the Agency is
retaining the 10X FQPA safety factor for
assessing inhalation risk.
ii. There is no indication that
flumioxazin is a neurotoxic chemical
and there is no need for a
developmental neurotoxicity study or
additional UFs to account for
neurotoxicity.
iii. There is evidence that flumioxazin
may result in increased susceptibility in
in utero rats or rabbits in the prenatal
developmental studies or in young rats
in the 2-generation reproduction study.
The Agency concluded that while there
is an increased susceptibility, there is a
low concern and no residual
uncertainties for pre-and/or postnatal
toxicity because the developmental
toxicity NOAELs/LOAELs are well
characterized after oral and dermal
exposure; the offspring toxicity NOAEL
and LOAEL are well characterized in
the reproduction study; and the doses
and endpoints have been selected from
the developmental and reproductive
PO 00000
Frm 00207
Fmt 4700
Sfmt 4700
91849
toxicity studies for the relevant
populations, except for the chronic
dietary endpoint, for which a chronic
study was chosen. Therefore, the
regulatory endpoints for flumioxazin are
protective of the increased susceptibility
seen in the developmental and
reproduction studies, and there are no
residual concerns for these effects.
iv. There are no residual uncertainties
identified in the exposure databases.
The dietary food exposure assessments
were performed based on 100 PCT and
tolerance-level residues. EPA made
conservative (protective) assumptions in
the ground and surface water modeling
used to assess exposure to flumioxazin
in drinking water. EPA used similarly
conservative assumptions to assess
postapplication exposure of children as
well as incidental oral exposure of
toddlers. These assessments will not
underestimate the exposure and risks
posed by flumioxazin.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
exposure from food and water to
flumioxazin will occupy 76% of the
aPAD for females 13–49 years old, the
population group receiving the greatest
exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to flumioxazin
from food and water will utilize 44% of
the cPAD for all infants <1 year old, the
population group receiving the greatest
exposure. Based on the explanation in
Unit III.C.3., regarding residential use
patterns, chronic residential exposure to
residues of flumioxazin is not expected.
3. Short and intermediate-term risk.
Short-term and intermediate-term
aggregate exposure takes into account
short-term and intermediate residential
exposure plus chronic exposure to food
and water (considered to be a
background exposure level).
Flumioxazin is currently registered for
uses that could result in short-term and
E:\FR\FM\19DER1.SGM
19DER1
91850
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
intermediate residential exposures, and
the Agency has determined that it is
appropriate to aggregate chronic
exposure through food and water with
short-term and intermediate-term
residential exposures to flumioxazin.
Since the Agency has determined that
the short-term and intermediate-term
points of departure are the same the
aggregate risks are the same for both
short-term and intermediate-term
exposures.
Using the exposure assumptions
described in this unit for short-term and
intermediate-term exposures, EPA has
concluded the combined short-term and
intermediate-term food, water, and
residential exposures result in aggregate
MOEs of 110 for adult females 13–49
years and 200 for children less than two
years. Because EPA’s level of concern
for flumioxazin is a MOE of 100 or
below, these MOEs are not of concern.
4. Aggregate cancer risk for U.S.
population. Based on the lack of
evidence of carcinogenicity in two
adequate rodent carcinogenicity studies,
flumioxazin is not expected to pose a
cancer risk to humans.
5. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
from aggregate exposure to flumioxazin
residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
(gas chromatography (GC) using a
nitrogen phosphorous detector (NPD)) is
available to enforce the tolerance
expression. The method may be
requested from: Chief, Analytical
Chemistry Branch, Environmental
Science Center, 701 Mapes Rd., Ft.
Meade, MD 20755–5350; telephone
number: (410) 305–2905; email address:
residuemethods@epa.gov.
srobinson on DSK5SPTVN1PROD with RULES
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level. The Codex has not
established any MRLs for flumioxazin.
C. Response to Comments
EPA received five comments to the
two published Notice of Filings. Two
comments stated, in part and without
any supporting information, that EPA
should deny this petition because it is
a harmful and toxic chemical with no
benefits. The Agency recognizes that
some individuals believe that pesticides
should be banned on agricultural crops.
The existing legal framework provided
by section 408 of the FFDCA, however,
states that tolerances may be set when
persons seeking such tolerances or
exemptions have demonstrated that the
pesticide meets the safety stand
imposed by that statute. EPA has
assessed the effects of this chemical on
human health and determined that
aggregate exposure to it will be safe.
These comments provide no
information to support an alternative
conclusion.
Another comment submitted by the
Center for Biological Diversity was
primarily concerned about the
environmental risks and Agency
compliance with any relevant
obligations under the Endangered
Species Act. This comment is not
relevant to the Agency’s evaluation of
safety of the flumioxazin tolerances;
section 408 of the FFDCA focuses on
potential harms to human health and
does not permit consideration of effects
on the environment. Additional
comments were submitted in support of
this petition by Interregional Research
Project Number 4 (IR–4) and Dr. A.
Stanley Culpepper from the University
of Georgia Cooperative Extension.
D. Revisions to Petitioned-For
Tolerances
The petitioner proposed a tolerance of
flumioxazin on caneberries at 0.4 ppm.
Both the petitioner and the Agency used
the Organization for Economic
Cooperation & Development (OECD)
spreadsheet calculator; however, the
Agency did not consider the two Oregon
trials to be independent since they were
conducted at the same location on the
same variety of raspberries and
applications were made within 30 days
of each other. Therefore, the four
samples were accounted as two,
resulting in an Agency recommended
tolerance of 0.5 ppm. All other
PO 00000
Frm 00208
Fmt 4700
Sfmt 4700
tolerances are recommended to be at the
same levels as petitioned.
The petitioner proposed a tolerance
for head and stem brassica, subgroup 5A
at 0.02 ppm; however, the EPA is
establishing a tolerance for Vegetable,
brassica, head and stem, group 5–16 at
0.02 ppm. In the Federal Register of
May 3, 2016 (81 FR 26471) (FRL–9944–
87) establishing the Vegetable, brassica,
head and stem, group 5–16, EPA
indicated that, for existing petitions for
which a Notice of Filing had been
published, the Agency would attempt to
conform these petitions to the rule.
Therefore, consistent with this rule,
EPA is establishing tolerances on
Vegetable, brassica, head and stem,
group 5–16 rather than head and stem
brassica, subgroup 5A. EPA concludes it
is reasonable to revise the petitioned-for
tolerance so that they agree with the
recent crop grouping revisions because
(1) the new crop group includes the
same commodities as the subgroup
except two commodities are no longer
in the group and (2) the representative
commodities for the revised crop
groups/subgroups have not changed.
Finally, the Agency is establishing
tolerances for clover, forage and clover,
hay with regional registrations in (c)
since residue field trial data were only
submitted to support registration in
Idaho, Washington, and Oregon.
V. Conclusion
Therefore, tolerances are established
for residues of flumioxazin, 2-[7-fluoro3,4-dihydro-3-oxo-4-(2-propynyl)-2H1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro1H-isoindole-1,3(2H)-dione, in or on
tolerances for residues of the herbicide
flumioxazin, 2-[7-fluoro-3,4-dihydro-3oxo-4-(2-propynyl)-2H-1,4-benzoxazin6-yl]-4,5,6,7-tetrahydro-1H-isoindole1,3(2H)-dione, in or on, berry, low
growing, subgroup 13–07G at 0.07 parts
per million (ppm); caneberry, subgroup
13–07A at 0.5 ppm; citrus, group 10–10
at 0.02 ppm; fruit, pome, group 11 at
0.02 ppm; fruit, stone, group 12 at 0.02
ppm; nut, tree, group 14–12 at 0.02
ppm; onion, bulb subgroup 3–07A at
0.02 ppm; small fruit, vine climbing,
except for fuzzy kiwifruit, subgroup 13–
07F at 0.02 ppm; vegetable, brassica,
head and stem, group 5–16 at 0.02 ppm;
and vegetable, fruiting, group 8–10 at
0.02 ppm.
Additionally, EPA is establishing
tolerances with regional registrations for
clover, forage at 0.02 ppm and clover,
hay at 0.15 ppm. Finally, the EPA is
removing tolerances for Cabbage at 0.02
ppm; cabbage, Chinese, napa at 0.02
ppm; fruit, pome group 11 at 0.02 ppm;
fruit, stone, group 12 at 0.02 ppm; garlic
at 0.02 ppm; grape at 0.02 ppm; nut, tree
E:\FR\FM\19DER1.SGM
19DER1
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
srobinson on DSK5SPTVN1PROD with RULES
group 14 at 0.02 ppm; okra at 0.02 ppm;
onion, bulb at 0.02 ppm; pistachio at
0.02 ppm; shallot bulb at 0.02 ppm;
strawberry at 0.07 ppm and vegetable,
fruiting group 8 at 0.02 ppm since these
will be superseded by this action.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerances in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or tribes, nor does
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this action. In addition, this action
does not impose any enforceable duty or
contain any unfunded mandate as
described under Title II of the Unfunded
Mandates Reform Act (UMRA) (2 U.S.C.
1501 et seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: December 6, 2016.
Daniel J. Rosenblatt,
Acting Director, Registration Division, Office
of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
■
2. Revise § 180.568 to read as follows:
§ 180.568 Flumioxazin; tolerances for
residues.
(a) General. Tolerances are
established for residues of flumioxazin,
2-[7-fluoro-3,4-dihydro-3-oxo-4-(2propynyl)-2H-1,4-benzoxazin-6-yl]4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)dione, including its metabolites and
degradates, in or on the commodities in
the table below. Compliance with the
tolerance levels specified below is to be
determined by measuring only
flumioxazin.
Alfalfa, forage ...............................
Alfalfa, hay ....................................
Almond, hulls ................................
Frm 00209
Fmt 4700
Artichoke, globe ............................
Asparagus .....................................
Berry, low growing, subgroup 13–
07G ...........................................
Bushberry subgroup 13–07B ........
Caneberry, subgroup 13–07A ......
Citrus, group 10–10 ......................
Citrus, oil .......................................
Corn, field, forage .........................
Corn, field, grain ...........................
Corn, field, stover .........................
Cotton, gin byproducts .................
Cotton, undelinted seed ...............
Fish, freshwater ............................
Fruit, pome, group 11–10 .............
Fruit, small vine climbing, except
for fuzzy kiwifruit, subgroup 13–
07F ............................................
Fruit, stone, group 12–12 .............
Grain, aspirated fractions .............
Hop, dried cones ..........................
Leaf petioles subgroup 4B ...........
Nut, tree, group 14–12 .................
Olive ..............................................
Onion, bulb subgroup 3–07A .......
Pea and bean, dried shelled, except soybean, subgroup 6C ......
Peanut ..........................................
Peppermint, tops ..........................
Pomegranate ................................
Prickly pear, fruit ...........................
Prickly pear, pads .........................
Rapeseed subgroup 20A ..............
Soybean forage ............................
Soybean hay .................................
Soybean, seed ..............................
Spearmint, tops ............................
Sugarcane, cane ..........................
Sunflower subgroup 20B ..............
Vegetable, brassica, head and
stem, group 5–16 ......................
Vegetable, cucurbit, group 9 ........
Vegetable, fruiting, group 8–10 ....
Vegetable, tuberous and corm,
subgroup 1C .............................
Wheat, forage ...............................
Wheat, grain .................................
Wheat, hay ...................................
Wheat, straw .................................
Sfmt 4700
3.0
8.0
0.70
Parts per
million
0.02
0.02
0.07
0.02
0.50
0.02
0.1
0.02
0.02
0.02
0.60
0.02
1.5
0.02
0.02
0.02
100
0.05
0.02
0.02
0.02
0.02
0.07
0.02
0.04
0.02
0.07
0.06
0.40
0.03
0.02
0.02
0.04
0.20
0.50
0.02
0.03
0.02
0.02
0.02
0.40
0.02
6.0
(b) Section 18 emergency exemptions.
[Reserved]
(c) Tolerances with regional
registrations. Tolerances are established
for residues of flumioxazin, 2-[7-fluoro3,4-dihydro-3-oxo-4-(2-propynyl)-2H1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro1H-isoindole-1,3(2H)-dione, including
its metabolites and degradates, in or on
the commodities in the table below.
Compliance with the tolerance levels
specified below is to be determined by
measuring only flumioxazin.
Parts per
million
Commodity
PO 00000
Commodity
91851
Commodity
Clover, forage ...............................
Clover, hay ...................................
E:\FR\FM\19DER1.SGM
19DER1
Parts per
million
0.02
0.15
91852
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Rules and Regulations
(d) Indirect or inadvertent residues.
[Reserved]
[FR Doc. 2016–30467 Filed 12–16–16; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
42 CFR Part 59
RIN 937–AA04
Compliance With Title X Requirements
by Project Recipients in Selecting
Subrecipients
Office of Population Affairs,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Final rule.
AGENCY:
The Department is amending
the regulations that apply to Title X
Project Grants for Family Planning
Services. The final rule amends
eligibility requirements to require that
no recipient making subawards for the
provision of services as part of its Title
X project may prohibit an entity from
participating for reasons other than its
ability to provide Title X services.
DATES: This Rule is effective on January
18, 2017.
FOR FURTHER INFORMATION CONTACT:
Susan B. Moskosky, MS, WHNP–BC,
Office of Population Affairs (OPA), 200
Independence Avenue SW., Suite 716G,
Washington, DC 20201; telephone (240)
453–2800; email: OPA_Resource@
hhs.gov.
SUPPLEMENTARY INFORMATION: On
September 7, 2016, The Department
issued a proposed rule seeking comment
on amending eligibility criteria under
the Title X family planning services
program so that no recipient making
subawards for the provision of services
as part of its Title X project may
prohibit an entity from participating for
reasons unrelated to its ability to
provide Title X services effectively. 81
FR 61639. As reiterated below, the
proposed rule set forth the need for the
amendment and sought public input.
SUMMARY:
srobinson on DSK5SPTVN1PROD with RULES
I. Background
A. Title X Background
As discussed in the Notice of
Proposed Rule Making (NPRM), the
Title X Family Planning Program, Public
Health Service Act (PHSA) secs. 1001 et
seq. [42 U.S.C. 300], was enacted in
1970 as part of the Public Health Service
Act. Administered by the Office of
Population Affairs (OPA) within the
Office of the Assistant Secretary for
Health (OASH), Title X is the only
federal program focused solely on
VerDate Sep<11>2014
20:05 Dec 16, 2016
Jkt 241001
providing family planning and related
preventive services. In 2015, more than
4 million individuals received services
through more than 3,900 Title X-funded
health centers.1
Title X serves women, men, and
adolescents to enable individuals to
determine freely the number and
spacing of children. By law, services are
provided to low-income individuals at
no or reduced cost. Services provided
through Title X-funded health centers
assist in preventing unintended
pregnancies and achieving pregnancies
that result in positive birth outcomes.
These services include contraceptive
services, pregnancy testing and
counseling, preconception health
services, screening and treatment for
sexually transmitted diseases (STD),
HIV testing and referral for treatment,
services to aid with achieving
pregnancy, basic infertility services, and
screening for cervical and breast cancer.
By statute, Title X funds are not
available to programs where abortion is
a method of family planning (PHSA sec.
1008). Additionally, Title X
implementing regulations require that
all pregnancy options counseling shall
be neutral and nondirective. 42 CFR
59.5(a)(5)(ii).
The Title X statute authorizes the
Secretary ‘‘to make grants to and enter
into contracts with public or nonprofit
private entities to assist in the
establishment and operation of
voluntary family planning projects
which shall offer a broad range of
acceptable and effective family planning
methods and services (including natural
family planning methods, infertility
services, and services for adolescents).’’
PHSA sec. 1001(a). In addition, in
awarding Title X grants and contracts,
the Secretary must ‘‘take into account
the number of patients to be served, the
relative need of the applicant, and its
capacity to make rapid and effective use
of such assistance.’’ PHSA sec. 1001(b).
The statute also requires that local and
regional entities ‘‘shall be assured the
right to apply for direct grants and
contracts.’’ PHSA sec. 1001(b). The
statute delegates rulemaking authority
to the Secretary to set the terms and
conditions of these grants and contracts.
PHSA sec. 1006. These regulations were
last revised in 2000. 65 FR 41270 (July
3, 2000).
Title X regulations delineating the
criteria used to decide which family
planning projects to fund and in what
amount, include, among other factors,
1 Fowler, C.I., Gable, J., Wang, J., & Lasater, B.
(2016, August). Family Planning Annual Report:
2015 National Summary. Research Triangle Park,
NC: RTI International.
PO 00000
Frm 00210
Fmt 4700
Sfmt 4700
the extent to which family planning
services are needed locally, the number
of patients (and, in particular, lowincome individuals) to be served, and
the adequacy of the applicant’s facilities
and staff. 42 CFR 59.7. Project recipients
receive funds directly from the federal
government following a competitive
process. The project recipients may
elect to provide Title X services directly,
subaward funds to subrecipients, or
both. The Department is responsible for
monitoring and evaluating the project
recipient’s performance and outcomes,
and each project recipient that
subawards to eligible subrecipients is
responsible for monitoring the
performance and outcomes of those
subrecipients. The subrecipients must
meet the same federal requirements as
the project recipients, including being a
public or private nonprofit entity, and
adhering to all Title X and other
applicable federal requirements. In the
event of poor performance or
noncompliance, a project recipient may
take enforcement actions as described in
the uniform grants rules at 45 CFR
75.371.
B. State Restrictions on Subrecipients
In the past several years, a number of
states have taken actions to restrict
participation by certain types of
providers as subrecipients in the Title X
program, for reasons other than the
provider’s ability to provide Title X
services. In at least several instances,
this has led to disruption of services or
reduction of services. Since 2011, 13
states have placed restrictions on or
eliminated subawards with specific
types of providers based on reasons
other than their ability to provide Title
X services. In several instances, these
restrictions have interfered with the
‘‘capacity [of the applicant] to make
rapid and effective use of [Title X
federal] assistance.’’ PHSA sec. 1001(b).
Moreover, states that restrict eligibility
of subrecipients have caused limitations
in the geographic distribution of
services and decreased access to
services through trusted providers.
States have restricted subrecipients
from participating in the Title X
program in several ways. Some states
have employed a tiered approach to
compete or distribute Title X funds,
whereby entities such as comprehensive
primary care providers, state health
departments, or community health
centers receive a preference in the
distribution of Title X funds. This
approach effectively excludes providers
focused on reproductive health from
receiving funds, even though they have
been shown to provide higher quality
services, such as preconception
E:\FR\FM\19DER1.SGM
19DER1
Agencies
[Federal Register Volume 81, Number 243 (Monday, December 19, 2016)]
[Rules and Regulations]
[Pages 91846-91852]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30467]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2015-0658; FRL-9955-45]
Flumioxazin; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
flumioxazin in or on multiple commodities which are identified and
discussed later in this document. The Inter-Regional Research Project
Number 4 (IR-4) requested these tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective December 19, 2016. Objections and
requests for hearings must be received on or before February 17, 2017,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2015-0658, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805. Please review the visitor instructions and
additional information about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; Main telephone
number: (703) 305-7090; email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Printing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must
[[Page 91847]]
identify docket ID number EPA-HQ-OPP-2015-0658 in the subject line on
the first page of your submission. All objections and requests for a
hearing must be in writing, and must be received by the Hearing Clerk
on or before February 17, 2017. Addresses for mail and hand delivery of
objections and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2015-0658, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of November 23, 2015 (80 FR 72941) (FRL-
9936-73), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition
(PP#5E8399) by Interregional Research No. 4 (IR-4), Rutgers, The State
University of New Jersey, 500 College Road East, Suite 201-W,
Princeton, NJ 08540. The Agency inadvertently republished this notice
on March 16, 2016 (81 FR 14030) (FRL-9942-86). The petition requested
that 40 CFR 180.568 be amended by establishing tolerances for residues
of the herbicide flumioxazin, 2-[7-fluoro-3,4-dihydro-3-oxo-4-(2-
propynyl)-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-
1,3(2H)-dione, in or on berry, low growing, subgroup 13-07G at 0.07
parts per million (ppm); caneberry, subgroup 13-07A at 0.4 ppm; citrus,
group 10-10 at 0.02 ppm; citrus oil at 0.1 ppm; clover, forage at 0.02
ppm; clover, hay at 0.15 ppm; fruit, pome, group 11-10 at 0.02 ppm;
fruit, small vine climbing, except for fuzzy kiwifruit, subgroup 13-07F
at 0.02 ppm; fruit, stone, group 12-12 at 0.02 ppm; head and stem
brassica, subgroup 5A at 0.02 ppm; nut, tree, group 14-12 at 0.02 ppm;
onion, bulb subgroup 3-07A at 0.02 ppm; and vegetable, fruiting, group
8-10 at 0.02 ppm.
The petitioner also requested the removal of the following
established tolerances based on the establishment of tolerances for the
commodities established in this action: Cabbage at 0.02 ppm; cabbage,
Chinese, napa at 0.02 ppm; fruit, pome group 11 at 0.02 ppm; fruit,
stone, group 12 at 0.02 ppm; garlic at 0.02 ppm; grape at 0.02 ppm;
nut, tree group 14 at 0.02 ppm; okra at 0.02 ppm; onion, bulb at 0.02
ppm; pistachio at 0.02 ppm; shallot bulb at 0.02 ppm; strawberry at
0.07 ppm; and vegetable, fruiting group 8 at 0.02 ppm. That document
referenced a summary of the petition prepared by Valent USA
Corporation, the registrant, which is available in the docket, https://www.regulations.gov. Comments were received on these notices of
filings. EPA's response to these comments is discussed in Unit IV.C.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue . .
. .''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for flumioxazin including exposure
resulting from the tolerances established by this action. EPA's
assessment of exposures and risks associated with flumioxazin follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
Toxicity associated with flumioxazin includes anemia and effects on
the cardiovascular system and liver. Specifically, alterations in
hemoglobin parameters were observed in rats, as well as increased renal
toxicity in male rats, and increased absolute and relative liver
weights and increased alkaline phosphate values were seen in dogs. No
evidence of neurotoxicity was seen in male or female rats in the acute
or subchronic neurotoxicity studies. The oral and dermal developmental
rat studies showed evidence of increased quantitative susceptibility of
fetuses, as cardiovascular anomalies (ventral septal defects) were
found. These developmental effects in the offspring were more severe
and seen at doses lower than those that caused parental and systemic
toxicity. The regulatory endpoints for flumioxazin are protective of
this increased susceptibility, however, so there is low concern and no
residual uncertainties for these effects. Flumioxazin was negative for
mutagenicity in most of the available studies, however, there were
aberrations in a chromosomal aberration assay. The lack of
carcinogenicity in mice and rats permits flumioxazin to be classified
as ``not likely to be carcinogenic to humans.''
Specific information on the studies received and the nature of the
adverse effects caused by flumioxazin as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov in document Flumioxazin: Human Health Risk
Assessment for the New Uses on Clover Grown for Seed; Citrus Group 10-
10; Caneberry Subgroup 13-07A; Head and Stem Brassica Subgroup 5A; and
Crop Group Expansion for Fruiting Vegetable Group 8-10; Low Growing
Berry Subgroup 13-07G; Nut Tree Group 14-12; Onion Bulb Subgroup 3-07A;
Pome
[[Page 91848]]
Fruit Group 11-10; Small Fruit, Vine Climbing, Except Fuzzy Kiwifruit
Subgroup 13-07F; and Stone Fruit Group 12-12 at pages 15-22 and 42-55
in docket ID number EPA-HQ-OPP-2015-0658.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/assessing-human-health-risk-pesticides.
A summary of the toxicological endpoints for flumioxazin used for
human risk assessment is discussed in Unit III, B of the final rule
published in the Federal Register of September 21, 2012 (77 FR 58493)
(FRL-9358-3).
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to flumioxazin, EPA considered exposure under the petitioned-
for tolerances as well as all existing flumioxazin tolerances in 40 CFR
180.568. EPA assessed dietary exposures from flumioxazin in food as
follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
Such effects were identified for flumioxazin for females 13-49. In
estimating acute dietary exposure, EPA used food consumption
information from the Dietary Exposure Evaluation Model software with
the Food Commodity Intake Database (DEEM-FCID) Version 3.16. This
software uses 2003-2008 food consumption data from the U.S. Department
of Agriculture's (USDA's) National Health and Nutrition Examination
Survey, What We Eat in America, (NHANES/WWEIA). As to residue levels in
food, EPA incorporated tolerance-level residues, 100 percent crop
treated (PCT) for all commodities and DEEM-FCID version 3.16.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the DEEM-FCID Version 3.16. This software uses
2003-2008 food consumption data from USDA's NHANES/WWEIA. As to residue
levels in food, EPA incorporated tolerance-level residues, 100 PCT for
all commodities.
iii. Cancer. Based on the data summarized in Unit III.A., EPA has
concluded that flumioxazin does not pose a cancer risk to humans.
Therefore, a dietary exposure assessment for the purpose of assessing
cancer risk is unnecessary.
iv. Anticipated residue and percent crop treated (PCT) information.
EPA did not use anticipated residue and/or PCT information in the
dietary assessment for flumioxazin. Tolerance level residues and/or
100% CT were assumed for all food commodities.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for flumioxazin in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of flumioxazin. The estimated drinking water
concentrations (EDWCs) are based on aquatic rates of the residues of
concern for flumioxazin and its major degradates (482-HA, and APF),
expressed as flumioxazin equivalents. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/about-water-exposure-models-used-pesticide.
Based on the First Index Reservoir Screening Tool (FIRST) model,
the EDWCs in surface water for acute exposures are 400 parts per
billion (ppb) for flumioxazin only and for chronic exposures are
estimated to be 9.4 ppb, 21.6 ppb, and 110.1 ppb for flumioxazin, 482-
HA and APF degradates, respectively, for a total concentration of 141
ppb. Based on the Screening Concentration in Ground Water (SCI-GROW)
model, for both acute and chronic (non-cancer) exposures, the EDWCs of
482-HA and APF are estimated to be 45.27 ppb and 2.66 ppb,
respectively, for ground water. EDWCs of flumioxazin are estimated to
be negligible in ground water for chronic exposures.
Estimates of drinking water concentrations were directly entered
into the dietary exposure model as follows. The peak day zero of 0.400
ppm for flumioxazin (degradates 482-HA and APF were not detected) was
used to assess the contribution to drinking water for the acute dietary
risk assessment, and the day 30 total of 0.141 ppm for flumioxazin,
482-HA and APF degradates was used to assess the contribution to
drinking water for the chronic dietary risk assessment.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets). Flumioxazin is
currently registered for the following uses that could result in
residential exposures: Turf, gardens and trees, and aquatic weeds. EPA
assessed residential exposure with the assumption that homeowner
handlers wear shorts, short-sleeved shirts, socks, and shoes, and that
they complete all tasks associated with the use of a pesticide product
including mixing/loading, if needed, as well as the application.
Residential handler exposure scenarios for both dermal and inhalation
are considered to be short-term only, due to the infrequent use
patterns associated with homeowner products.
EPA uses the term ``post-application'' to describe exposure to
individuals that occur as a result of being in an environment that has
been previously treated with a pesticide. Flumioxazin can be used in
many areas that can be frequented by the general population including
residential areas, lakes, and ponds. As a result, individuals can be
exposed by entering these areas if they have been previously treated.
Therefore, short-term and intermediate-term dermal post-application
exposures and risks were assessed for adults and children. In addition,
oral post-application exposures and risks were assessed for children to
be protective of possible hand-to-mouth, object-to-mouth, and soil
ingestion activities that may occur on treated turf areas. Further
information regarding EPA standard assumptions and generic inputs for
[[Page 91849]]
residential exposures may be found at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/standard-operating-procedures-residential-pesticide.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found flumioxazin to share a common mechanism of
toxicity with any other substances, and flumioxazin does not appear to
produce a toxic metabolite produced by other substances. For the
purposes of this tolerance action, therefore, EPA has assumed that
flumioxazin does not have a common mechanism of toxicity with other
substances. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's Web site at https://www2.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA Safety
Factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. There is evidence of
increased quantitative susceptibility of fetuses in the oral and dermal
developmental rat studies, where cardiovascular abnormalities occurred
in the absence of maternal toxicity. The rat reproduction study also
showed evidence of qualitative and quantitative post-natal
susceptibility since reproductive effects in offspring were more severe
and were seen at lower doses than those that caused parental/systemic
toxicity. Even with this observed increased susceptibility, the Agency
has concluded there is a low concern and no residual uncertainties for
pre- and/or postnatal toxicity because the developmental toxicity
NOAELs/LOAELs are well-characterized after oral and dermal exposure,
and the offspring toxicity NOAEL and LOAEL are well characterized in
the reproduction study.
Furthermore, the doses and endpoints have been selected from the
developmental and reproductive toxicity studies for risk assessment of
the relevant exposed populations (e.g., pregnant females and children),
with the exception of the chronic dietary endpoint, for which a chronic
study was selected. Therefore, regulatory endpoints for flumioxazin are
protective of the increased susceptibility and there are no residual
concerns for these effects.
3. Conclusion. EPA has determined that reliable data show the
safety of infants and children would be adequately protected if the
FQPA SF were reduced to 1X for oral and dermal exposures, but retained
at 10X for inhalation exposures due to the lack of an inhalation study.
That decision is based on the following findings:
i. The toxicity database for flumioxazin is sufficient for
assessing the toxicity and characterizing the hazard of flumioxazin. An
inhalation study is needed to characterize more completely the
potential for adverse effects associated with the inhalation route of
exposure; therefore, in order to account for any uncertainty attending
the use of the dose and endpoint from an oral rat developmental
toxicity study with an estimated 100% default absorption factor, the
Agency is retaining the 10X FQPA safety factor for assessing inhalation
risk.
ii. There is no indication that flumioxazin is a neurotoxic
chemical and there is no need for a developmental neurotoxicity study
or additional UFs to account for neurotoxicity.
iii. There is evidence that flumioxazin may result in increased
susceptibility in in utero rats or rabbits in the prenatal
developmental studies or in young rats in the 2-generation reproduction
study. The Agency concluded that while there is an increased
susceptibility, there is a low concern and no residual uncertainties
for pre-and/or postnatal toxicity because the developmental toxicity
NOAELs/LOAELs are well characterized after oral and dermal exposure;
the offspring toxicity NOAEL and LOAEL are well characterized in the
reproduction study; and the doses and endpoints have been selected from
the developmental and reproductive toxicity studies for the relevant
populations, except for the chronic dietary endpoint, for which a
chronic study was chosen. Therefore, the regulatory endpoints for
flumioxazin are protective of the increased susceptibility seen in the
developmental and reproduction studies, and there are no residual
concerns for these effects.
iv. There are no residual uncertainties identified in the exposure
databases. The dietary food exposure assessments were performed based
on 100 PCT and tolerance-level residues. EPA made conservative
(protective) assumptions in the ground and surface water modeling used
to assess exposure to flumioxazin in drinking water. EPA used similarly
conservative assumptions to assess postapplication exposure of children
as well as incidental oral exposure of toddlers. These assessments will
not underestimate the exposure and risks posed by flumioxazin.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. Using the exposure assumptions discussed in this
unit for acute exposure, the acute dietary exposure from food and water
to flumioxazin will occupy 76% of the aPAD for females 13-49 years old,
the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
flumioxazin from food and water will utilize 44% of the cPAD for all
infants <1 year old, the population group receiving the greatest
exposure. Based on the explanation in Unit III.C.3., regarding
residential use patterns, chronic residential exposure to residues of
flumioxazin is not expected.
3. Short and intermediate-term risk. Short-term and intermediate-
term aggregate exposure takes into account short-term and intermediate
residential exposure plus chronic exposure to food and water
(considered to be a background exposure level). Flumioxazin is
currently registered for uses that could result in short-term and
[[Page 91850]]
intermediate residential exposures, and the Agency has determined that
it is appropriate to aggregate chronic exposure through food and water
with short-term and intermediate-term residential exposures to
flumioxazin. Since the Agency has determined that the short-term and
intermediate-term points of departure are the same the aggregate risks
are the same for both short-term and intermediate-term exposures.
Using the exposure assumptions described in this unit for short-
term and intermediate-term exposures, EPA has concluded the combined
short-term and intermediate-term food, water, and residential exposures
result in aggregate MOEs of 110 for adult females 13-49 years and 200
for children less than two years. Because EPA's level of concern for
flumioxazin is a MOE of 100 or below, these MOEs are not of concern.
4. Aggregate cancer risk for U.S. population. Based on the lack of
evidence of carcinogenicity in two adequate rodent carcinogenicity
studies, flumioxazin is not expected to pose a cancer risk to humans.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to flumioxazin residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology (gas chromatography (GC) using a
nitrogen phosphorous detector (NPD)) is available to enforce the
tolerance expression. The method may be requested from: Chief,
Analytical Chemistry Branch, Environmental Science Center, 701 Mapes
Rd., Ft. Meade, MD 20755-5350; telephone number: (410) 305-2905; email
address: residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level. The Codex has not
established any MRLs for flumioxazin.
C. Response to Comments
EPA received five comments to the two published Notice of Filings.
Two comments stated, in part and without any supporting information,
that EPA should deny this petition because it is a harmful and toxic
chemical with no benefits. The Agency recognizes that some individuals
believe that pesticides should be banned on agricultural crops. The
existing legal framework provided by section 408 of the FFDCA, however,
states that tolerances may be set when persons seeking such tolerances
or exemptions have demonstrated that the pesticide meets the safety
stand imposed by that statute. EPA has assessed the effects of this
chemical on human health and determined that aggregate exposure to it
will be safe. These comments provide no information to support an
alternative conclusion.
Another comment submitted by the Center for Biological Diversity
was primarily concerned about the environmental risks and Agency
compliance with any relevant obligations under the Endangered Species
Act. This comment is not relevant to the Agency's evaluation of safety
of the flumioxazin tolerances; section 408 of the FFDCA focuses on
potential harms to human health and does not permit consideration of
effects on the environment. Additional comments were submitted in
support of this petition by Interregional Research Project Number 4
(IR-4) and Dr. A. Stanley Culpepper from the University of Georgia
Cooperative Extension.
D. Revisions to Petitioned-For Tolerances
The petitioner proposed a tolerance of flumioxazin on caneberries
at 0.4 ppm. Both the petitioner and the Agency used the Organization
for Economic Cooperation & Development (OECD) spreadsheet calculator;
however, the Agency did not consider the two Oregon trials to be
independent since they were conducted at the same location on the same
variety of raspberries and applications were made within 30 days of
each other. Therefore, the four samples were accounted as two,
resulting in an Agency recommended tolerance of 0.5 ppm. All other
tolerances are recommended to be at the same levels as petitioned.
The petitioner proposed a tolerance for head and stem brassica,
subgroup 5A at 0.02 ppm; however, the EPA is establishing a tolerance
for Vegetable, brassica, head and stem, group 5-16 at 0.02 ppm. In the
Federal Register of May 3, 2016 (81 FR 26471) (FRL-9944-87)
establishing the Vegetable, brassica, head and stem, group 5-16, EPA
indicated that, for existing petitions for which a Notice of Filing had
been published, the Agency would attempt to conform these petitions to
the rule. Therefore, consistent with this rule, EPA is establishing
tolerances on Vegetable, brassica, head and stem, group 5-16 rather
than head and stem brassica, subgroup 5A. EPA concludes it is
reasonable to revise the petitioned-for tolerance so that they agree
with the recent crop grouping revisions because (1) the new crop group
includes the same commodities as the subgroup except two commodities
are no longer in the group and (2) the representative commodities for
the revised crop groups/subgroups have not changed.
Finally, the Agency is establishing tolerances for clover, forage
and clover, hay with regional registrations in (c) since residue field
trial data were only submitted to support registration in Idaho,
Washington, and Oregon.
V. Conclusion
Therefore, tolerances are established for residues of flumioxazin,
2-[7-fluoro-3,4-dihydro-3-oxo-4-(2-propynyl)-2H-1,4-benzoxazin-6-yl]-
4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione, in or on tolerances for
residues of the herbicide flumioxazin, 2-[7-fluoro-3,4-dihydro-3-oxo-4-
(2-propynyl)-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-
1,3(2H)-dione, in or on, berry, low growing, subgroup 13-07G at 0.07
parts per million (ppm); caneberry, subgroup 13-07A at 0.5 ppm; citrus,
group 10-10 at 0.02 ppm; fruit, pome, group 11 at 0.02 ppm; fruit,
stone, group 12 at 0.02 ppm; nut, tree, group 14-12 at 0.02 ppm; onion,
bulb subgroup 3-07A at 0.02 ppm; small fruit, vine climbing, except for
fuzzy kiwifruit, subgroup 13-07F at 0.02 ppm; vegetable, brassica, head
and stem, group 5-16 at 0.02 ppm; and vegetable, fruiting, group 8-10
at 0.02 ppm.
Additionally, EPA is establishing tolerances with regional
registrations for clover, forage at 0.02 ppm and clover, hay at 0.15
ppm. Finally, the EPA is removing tolerances for Cabbage at 0.02 ppm;
cabbage, Chinese, napa at 0.02 ppm; fruit, pome group 11 at 0.02 ppm;
fruit, stone, group 12 at 0.02 ppm; garlic at 0.02 ppm; grape at 0.02
ppm; nut, tree
[[Page 91851]]
group 14 at 0.02 ppm; okra at 0.02 ppm; onion, bulb at 0.02 ppm;
pistachio at 0.02 ppm; shallot bulb at 0.02 ppm; strawberry at 0.07 ppm
and vegetable, fruiting group 8 at 0.02 ppm since these will be
superseded by this action.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerances in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: December 6, 2016.
Daniel J. Rosenblatt,
Acting Director, Registration Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Revise Sec. 180.568 to read as follows:
Sec. 180.568 Flumioxazin; tolerances for residues.
(a) General. Tolerances are established for residues of
flumioxazin, 2-[7-fluoro-3,4-dihydro-3-oxo-4-(2-propynyl)-2H-1,4-
benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione,
including its metabolites and degradates, in or on the commodities in
the table below. Compliance with the tolerance levels specified below
is to be determined by measuring only flumioxazin.
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Alfalfa, forage.............................................. 3.0
Alfalfa, hay................................................. 8.0
Almond, hulls................................................ 0.70
Artichoke, globe............................................. 0.02
Asparagus.................................................... 0.02
Berry, low growing, subgroup 13-07G.......................... 0.07
Bushberry subgroup 13-07B.................................... 0.02
Caneberry, subgroup 13-07A................................... 0.50
Citrus, group 10-10.......................................... 0.02
Citrus, oil.................................................. 0.1
Corn, field, forage.......................................... 0.02
Corn, field, grain........................................... 0.02
Corn, field, stover.......................................... 0.02
Cotton, gin byproducts....................................... 0.60
Cotton, undelinted seed...................................... 0.02
Fish, freshwater............................................. 1.5
Fruit, pome, group 11-10..................................... 0.02
Fruit, small vine climbing, except for fuzzy kiwifruit, 0.02
subgroup 13-07F.............................................
Fruit, stone, group 12-12.................................... 0.02
Grain, aspirated fractions................................... 100
Hop, dried cones............................................. 0.05
Leaf petioles subgroup 4B.................................... 0.02
Nut, tree, group 14-12....................................... 0.02
Olive........................................................ 0.02
Onion, bulb subgroup 3-07A................................... 0.02
Pea and bean, dried shelled, except soybean, subgroup 6C..... 0.07
Peanut....................................................... 0.02
Peppermint, tops............................................. 0.04
Pomegranate.................................................. 0.02
Prickly pear, fruit.......................................... 0.07
Prickly pear, pads........................................... 0.06
Rapeseed subgroup 20A........................................ 0.40
Soybean forage............................................... 0.03
Soybean hay.................................................. 0.02
Soybean, seed................................................ 0.02
Spearmint, tops.............................................. 0.04
Sugarcane, cane.............................................. 0.20
Sunflower subgroup 20B....................................... 0.50
Vegetable, brassica, head and stem, group 5-16............... 0.02
Vegetable, cucurbit, group 9................................. 0.03
Vegetable, fruiting, group 8-10.............................. 0.02
Vegetable, tuberous and corm, subgroup 1C.................... 0.02
Wheat, forage................................................ 0.02
Wheat, grain................................................. 0.40
Wheat, hay................................................... 0.02
Wheat, straw................................................. 6.0
------------------------------------------------------------------------
(b) Section 18 emergency exemptions. [Reserved]
(c) Tolerances with regional registrations. Tolerances are
established for residues of flumioxazin, 2-[7-fluoro-3,4-dihydro-3-oxo-
4-(2-propynyl)-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-
1,3(2H)-dione, including its metabolites and degradates, in or on the
commodities in the table below. Compliance with the tolerance levels
specified below is to be determined by measuring only flumioxazin.
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Clover, forage............................................... 0.02
Clover, hay.................................................. 0.15
------------------------------------------------------------------------
[[Page 91852]]
(d) Indirect or inadvertent residues. [Reserved]
[FR Doc. 2016-30467 Filed 12-16-16; 8:45 am]
BILLING CODE 6560-50-P